CongenPharma

Founded in 2013 and headquartered in Guangzhou, CongenPharma specializes in pharmaceutical peptide intermediates, cosmetic peptides and ingredients. With our EMPHASES^® synthesis platform, we have become a trusted manufacturer in the peptide industry, serving over 500 customers worldwide.

We owned a 2,000+ sqm R&D center and pilot lab with two manufacturing facilities—one fully operational and another under construction. CongenPharma has applied for over 40 patents with 30 granted (USA and Japan) and over 100 trademarks with 74 approved.

Our New LPPS – EMPHASES^® Peptide Synthesis Technology uses soluble carriers to replace traditional insoluble solid-phase resin, enabling fast reaction speeds, reduced consumption (amino acids, reagents, and solvents), simplified post-processing and broad applicability. This innovative platform ensures high purity, excellent efficacy and lower-cost peptide synthesis, while supporting green and sustainable peptide synthesis.

40 +

Patents

2000 +

R&D Center (㎡)

12000 +

Manufacturing Base (㎡)

Mission

Making peptide synthesis greener and more sustainable

Vision

To be a world-renowned company in the peptide field

Value

Integrity, Innovation, Cooperation, Mutual Prosperity

Development History

2024

Development:
Reliable Manufacturer,KSM & Intermediates of semaglutide and Tirzepatide,side chains and Salcaprozate Sodium (SNAC)
Industrial land for peptides and cosmetic ingredient production is currently under development at Wengyuan in Shaoguan,Guangdong Province

2023

Layout:
Development of the GLP-1 pharmaceutical peptide industry chain, represented by semaglutide and tirzepatide.
Designated as :
a Provincial Specialized and Innovative SME
a Provincial Intellectual Property Demonstration Enterprise.

2020

Six sets of automatic peptide synthesizers.
EMPHASES^® Synthesis Platform.

2018

Breakthrough：
Patent applications filed for the new LPPS – EMPHASES^® Peptide Synthesis

2016

Technology–based SME
Technology Innovation Enterprises
National High–tech Enterprise

2015

Scale up
Expanding into the beauty and cosmetics market through the development of high-performance ingredients and cosmetic peptides, while advancing peptide synthesis technologies.

2013

CongenPharma
Established in 2013, recognized as a national high-tech enterprise.
Engaged in the R&D and manufacturing of APIs and intermediates for the pharmaceutical industry and cosmetic ingredients & peptides for the personal care sector.